U.S. Food and Drug Administration

FDA Greenlights Aqneursa for Niemann-Pick Disease Type C, Marking a Breakthrough in Rare Disease Treatment

WASHINGTON D.C. — The U.S. Food and Drug Administration (FDA) has made a landmark decision to approve Aqneursa (levacetylleucine) for the treatment of neurological symptoms linked to Niemann-Pick disease type C …

FDA Greenlights Aqneursa for Niemann-Pick Disease Type C, Marking a Breakthrough in Rare Disease Treatment Read More

Pennsylvania Health Officials Urge Vaccinations as Respiratory Season Begins

Shield Against the Season: Pennsylvania Health Experts Urge Vital Vaccinations for Flu, COVID-19, and RSV!

HARRISBURG, PA — As the respiratory disease season sets in, Pennsylvania’s health leaders emphasize the critical role of vaccinations in safeguarding public health. During a recent visit to a Harrisburg …

Shield Against the Season: Pennsylvania Health Experts Urge Vital Vaccinations for Flu, COVID-19, and RSV! Read More